Back to search
FDAFDA · Food and drugs·Recall number D-1260-2020

Epinephrine Injection USP, 0.3 mg (Auto-Injector), 0.3 mg/ 0.3 mL pre-filled syringe, Rx Only, Manufactured for Teva Pharmaceuticals USA, Inc. North Wales, PA 19454. NDC 0093-5986-27

Published May 13, 2020 · Recall initiated: March 5, 2020

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
EPINEPHRINE
Manufacturer
Teva Pharmaceuticals USA
Distributor
Product was distributed to 1 wholesaler who still had all units within their possession and had not shipped or further distributed any of the product.
UPC
0300935985275
Lot
Lot # 007F19AA, exp. date 04/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card